Investor Relations
Creating the active wellness testing category for serious athletes.
COR5 is not another passive wearable. We compress lab-style physiological testing into a 60–120 second active test athletes can run anywhere they train — using five synchronized signals, AI-assisted reading, and a personal baseline that gets smarter with every test.
What we’re building
We are not replacing the lab. We put it in athletes’ hands. COR5 brings active, multi-modal physiological measurement into gyms, rinks, locker rooms, hotels, sidelines, and team facilities — giving serious athletes and performance teams a clearer daily view of readiness, recovery, training stress, and load response.
-
Hardware
One dual-mode device — handheld and wearable — capturing cardiac, vascular, composition, thermal, and motion signals in a synchronized 60–120 second test, built for repeatable daily use wherever athletes train.
-
Intelligence
AI-assisted reading turns raw signals into 45 wellness and performance metrics, calibrated to each athlete’s own baseline instead of a population average.
-
Subscription
A device-led entry point with recurring subscriptions for individual athletes and teams, expanding from daily testing into trend analysis and coach-facing workflows.
-
Moat
Synchronized sensing, personal baselines, and repeated active tests compound into a data advantage that gets stronger the more each athlete uses COR5.
Where we are
- Signed LOI — up to 9,000 units: a single-client letter of intent for 1,000 units in 2026 and 8,000 in 2027, staged with pilot validation, with an additional 15,000 units in final paperwork — plus 8 ongoing pilots in daily field testing.
- NBA · NFL · NHL · MLS funnel: active conversations with teams and players.
- College programs: multiple programs in the pipeline.
- 5 pro teams: inbound interest from the field-testing cohort.
Who we work with
We’re selective about capital partners. We prioritize investors who:
- Have a long horizon and understand consumer hardware timelines.
- Bring domain expertise in health tech, performance, sports science, or vertical SaaS.
- Can introduce us to operators, distribution partners, or institutional users.
- Understand the regulatory posture of a non-medical performance and wellness device.
Pitch deck
Investor materials are password-protected. Qualified investors can request the password by emailing investors@cor5.com.
Get in touch
If you’re an accredited investor, a strategic partner, or a fund whose thesis lines up with ours, we’d be glad to share more.
Response within 5 business days
Important notice. This page is provided for informational purposes only. It does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. Any such offer or solicitation will be made only to qualified, accredited investors and only by means of definitive offering documents, including a private placement memorandum and subscription agreement, that contain detailed information about the company, the securities offered, and the associated risks.
Forward-looking statements on this page reflect current expectations and are subject to risks and uncertainties. Actual results may differ materially. COR5 is a performance and wellness device, not a medical device, and has not been evaluated or cleared by the FDA. Past performance, partnerships, or product traction are not indicative of future results.
By contacting investor relations, you agree that any information you submit may be reviewed by COR5 and its representatives in connection with potential investor due diligence.